> Omaha, Neb.-based TriMed Research has raised $5 million in its first round. Release
> Peregrine Pharmaceuticals is touting new clinical data supporting the broad anti-viral properties of Tarvacin. Release
> Celltrion, a joint venture of VaxGen, has inked a deal to manufacture biologics under development by Bristol-Myers Squibb. Release
> Organon says it will meet with FDA officials to address issues the agency has raised for its implantable contraceptive Implanon. Story
> Genelabs has received an orphan drug designation for its experimental lupus drug Prestara. Release
> Canada's Generex has started a research collaboration on an allergy therapy. Release
> Pfizer has begun work on a $90 million plant expansion in Ireland. Release
> Elite Pharmaceuticals and IntelliPharmaCeutics will jointly develop a controlled release product. Release
> Spain's Zeltia has launched a 100M euro share issue. Story
And finally...A doctor's troubled past took years to catch up with him in Australia. Article